Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 1942-1945

  Arnalich, Francisco ^a,c   Garcia Palomero, Esther ^a   López, Julia ^a   Jiménez, Manuel ^a   Madero, Rosario ^a   Renart, Jaime ^b   Vázquez, Juan José ^a   Montiel, Carmen ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c HOSPITAL INFANTIL LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MONONUCLEAR CELL; MORTALITY; PRIORITY JOURNAL; SEPSIS;

ADULT; AGED; CYTOKINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NF-KAPPA B; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034021896     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.1942-1945.2000     Document Type: Article

References (18)

1. Arnalich, F., J. López, R. Codoceo, M. Jiménez, R. Madero, and C. Montiel. 1999. Relationship of plasma leptin to plasma cytokines and survival in sepsis and septic shock. J. Infect. Dis. 180:908-911.
2. Böhrer, H., F. Qiu, T. Zimmermann, Y. Zhang, T. Jilmer, D. Mannel, B. W. Böttiger, D. M. Stern, R. Waldherr, H. D. Saeger, R. Ziegler, A. Bierhaus, and E. Martin. 1997. Role of NF-κ B in the mortality of sepsis. J. Clin. Investig. 100:972-985.
3. Bornstein, S. R., J. Licinio, L. R. Tauchnitz, L. Engelman, A. B. Negrao, P. Gold, and G. P. Chrousos. 1998. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm in cortisol and leptin secretion. J. Clin. Endocrinol. Metab. 83:280-283.
4. Calandra, T., J. D. Baumgartner, G. E. Grau, M. M. Wu, P. H. Lambert, J. Schellekens, J. Verhoef, M. P. Glauser, and the Swiss-Dutch J5 Immunoglobulin Study Group. 1990. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α and interferon-γ in the serum of patients with septic shock. J. Infect. Dis. 161:982-987.
5. Casey, L., R. A. Blak, and R. C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with sepsis. Ann. Intern. Med. 119: 771-778.
6. Chen, F., V. Castranova, X. Shi, and L. M. Demers. 1999. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem. 45:7-17.
7. Christman, J. W., L. H. Lancaster, and T. S. Blackwell. 1998. Nuclear factor-κB: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med. 24:1131-1138.
8. Damas, P., J. L. Canivet, D. De Groote, Y. Wrindts, A. Albert, P. Franchimont, and M. Lamy. 1997. Sepsis and serum cytokine concentrations. Crit. Care Med. 25:405-412.
9. Friedland, J. S., J. C. Porter, S. Daryanani, J. M. Bland, N. J. Screaton, M. J. J. Vessely, G. E. Griffin, E. D. Bennett, and D. G. Remick. 1996. Plasma proinflammatory concentrations, acute physiologic and chronic health evaluation (APACHE) III scores and survival in patients in an intensive care unit. Crit. Care Med. 24:1775-1781.
10. Gardlund, B., J. Sjolin, A. Nilsson, M. Roll, C. J. Wickerts, and B. Wretlind. 1995. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J. Infect. Dis. 172:296-301.
11. Granowitz, E. V., A. A. Santos, D. D. Poutsiaka, J. G. Cannon, D. W. Wilmore, S. M. Wolff, and C. A. Dinarello. 1991. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 338:1423-1424.
12. Knaus, W. A., E. A. Draper, D. P. Wagner, and J. E. Zimmermann. 1985. APACHE II: a severity of disease classification system. Crit. Care Med. 13:389-393.
13. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapy in sepsis. Crit. Care Med. 20:864-874.
14. Montaner, S., A. Ramos, R. Perona, P. Esteve, A. Carnero, and J. C. Lacal. 1995. Overexpression of PKC in NIH 3T3 cells does not induce cell transformation nor tumorigenicity and does not alter NF κB activity. Oncogene 10:2213-2220.
15. Schwartz, M. D., E. E. Moore, F. A. Moore, R. Shenkar, P. Moine, J. B. Haenel, and E. Abraham. 1996. Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit. Care Med. 24:1285-1292.
16. Van der Poll, T., R. de Waal Malefyt, S. M. Coyle, and S. F. Lowry. 1997. Antiinflammatory cytokine responses during sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin-1 receptor type II, IL-10, and IL-13. J. Infect. Dis. 175:118-122.
17. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64:4733-4738.
18. 2+ dependence, and differential half-site recognition. J. Biol. Chem. 266:252-260.